Mathematical models of diabetes progression.

Few attempts have been made to model mathematically the progression of type 2 diabetes. A realistic representation of the long-term physiological adaptation to developing insulin resistance is necessary for effectively designing clinical trials and evaluating diabetes prevention or disease modification therapies. Writing a good model for diabetes progression is difficult because the long time span of the disease makes experimental verification of modeling hypotheses extremely awkward. In this context, it is of primary importance that the assumptions underlying the model equations properly reflect established physiology and that the mathematical formulation of the model give rise only to physically plausible behavior of the solutions. In the present work, a model of the pancreatic islet compensation is formulated, its physiological assumptions are presented, some fundamental qualitative characteristics of its solutions are established, the numerical values assigned to its parameters are extensively discussed (also with reference to available cross-sectional epidemiologic data), and its performance over the span of a lifetime is simulated under various conditions, including worsening insulin resistance and primary replication defects. The differences with respect to two previously proposed models of diabetes progression are highlighted, and therefore, the model is proposed as a realistic, robust description of the evolution of the compensation of the glucose-insulin system in healthy and diabetic individuals. Model simulations can be run from the authors' web page.

[1]  V. Bolie,et al.  Coefficients of normal blood glucose regulation. , 1961, Journal of applied physiology.

[2]  P. Gallop,et al.  The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. , 1976, The Journal of clinical investigation.

[3]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[4]  P. Higgins,et al.  Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. , 1981, The Journal of biological chemistry.

[5]  I. Swenne.  The Role of Glucose in the In Vitro Regulation of Cell Cycle Kinetics and Proliferation of Fetal Pancreatic B-Cells , 1982, Diabetes.

[6]  Variations in hemoglobin A1c and blood glucose in children with newly diagnosed diabetes mellitus described by a biokinetic model. , 1984, Diabete & metabolisme.

[7]  M. Löhr,et al.  Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.

[8]  J. Leahy,et al.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. , 1986, The Journal of clinical investigation.

[9]  R N Bergman,et al.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.

[10]  G. Eisenbarth.  Type I diabetes mellitus. A chronic autoimmune disease. , 1986 .

[11]  R. DeFronzo.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[12]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[13]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[14]  J. Leahy,et al.  Compensatory Growth of Pancreatic β-Cells in Adult Rats After Short-Term Glucose Infusion , 1989, Diabetes.

[15]  S. Hager,et al.  Insulin resistance in normal rats infused with glucose for 72 h. , 1991, The American journal of physiology.

[16]  I. Godsland,et al.  Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. , 1992, The American journal of physiology.

[17]  D. Finegood,et al.  Markedly Reduced β-Cell Function Does Not Result in Insulin Resistance in Islet Autografted Dogs , 1992, Diabetes.

[18]  D. Eizirik,et al.  Human pancreatic beta-cell deoxyribonucleic acid-synthesis in islet grafts decreases with increasing organ donor age but increases in response to glucose stimulation in vitro. , 1996, Endocrinology.

[19]  D. Pipeleers,et al.  Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. , 1996, The Journal of clinical investigation.

[20]  D. Pipeleers,et al.  Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. , 1996, The Journal of clinical investigation.

[21]  R N Bergman,et al.  Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. , 1996, The Journal of clinical investigation.

[22]  L. Bouwens,et al.  Proliferation and differentiation in the human fetal endocrine pancreas , 1997, Diabetologia.

[23]  E. Kraegen,et al.  Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats. , 1997, The American journal of physiology.

[24]  D. Finegood,et al.  Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. , 1998, Diabetes.

[25]  L. Bouwens,et al.  Extra-insular beta cells associated with ductules are frequent in adult human pancreas , 1998, Diabetologia.

[26]  M. Berthault,et al.  Pancreatic beta-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. , 1998, Diabetes.

[27]  M. White,et al.  Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. , 1998, The Journal of biological chemistry.

[28]  B. Zhivotovsky,et al.  Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration. , 1998, The Journal of biological chemistry.

[29]  M. Laakso,et al.  Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. , 1999, The Journal of clinical endocrinology and metabolism.

[30]  M. Berthault,et al.  Neogenesis vs. apoptosis as main components of pancreatic β cell mass changes in glucose‐infused normal and mildly diabetic adult rats , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  D. Green,et al.  A Single Cell Analysis of Apoptosis: Ordering the Apoptotic Phenotype , 2000, Annals of the New York Academy of Sciences.

[32]  R. Miura,et al.  A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes. , 2000, Journal of theoretical biology.

[33]  G. Melino,et al.  High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. , 2001, Diabetes.

[34]  G. Striker.  Glucose toxicity. , 2001, Kidney International.

[35]  S. Kahn.  Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. , 2001, The Journal of clinical endocrinology and metabolism.

[36]  R. Walker,et al.  Diagnosing insulin resistance in the general population. , 2001, Diabetes care.

[37]  M. Donath,et al.  Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. , 2001, Diabetes.

[38]  S. Kahn,et al.  The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .

[39]  M. Ellenberg,et al.  Ellenberg and Rifkin's Diabetes Mellitus , 2002 .

[40]  Paul Vincent Spade,et al.  William of Ockham , 2002 .

[41]  Claudio Cobelli,et al.  Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. , 2002, Diabetes.

[42]  S. Yagihashi,et al.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients , 2002, Diabetologia.

[43]  David M. Eddy,et al.  Archimedes: a new model for simulating health care systems--the mathematical formulation , 2002, J. Biomed. Informatics.

[44]  Robert A Rizza,et al.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.

[45]  Jae-Hyoung Cho,et al.  Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .

[46]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[47]  R. Bergman,et al.  Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? , 2003, Diabetes care.

[48]  Claudio Cobelli,et al.  Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. , 2003, Diabetes.

[49]  David M Eddy,et al.  Validation of the archimedes diabetes model. , 2003, Diabetes care.

[50]  In Kyu Lee,et al.  Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. , 2003, The Journal of clinical endocrinology and metabolism.

[51]  Jonathan R T Lakey,et al.  Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. , 2004, Diabetes.

[52]  R. Goebbels,et al.  Cellular composition of the human diabetic pancreas , 1983, Diabetologia.

[53]  Masafumi Matsuda,et al.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[54]  R. Rizza,et al.  Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? , 2005, Diabetologia.

[55]  OP-142 gene expression profile of nonfunctional human pancreatic islets: predictors of transplant failure? , 2005, Transplantation proceedings.

[56]  Deanna J. M. Isaman,et al.  A computer simulation model of diabetes progression, quality of life, and cost. , 2005, Diabetes care.

[57]  Alvin C. Powers,et al.  Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[58]  B. Hering,et al.  Effect of Donor Age on Function of Isolated Human Islets , 2006, Diabetes.

[59]  W. Winter,et al.  A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[60]  Yang Kuang,et al.  Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview , 2006 .

[61]  Y. Kuang,et al.  Modeling the glucose-insulin regulatory system and ultradian insulin secretory oscillations with two explicit time delays. , 2006, Journal of theoretical biology.

[62]  Kathrin Maedler,et al.  Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. , 2006, Diabetes.

[63]  A Boutayeb,et al.  A critical review of mathematical models and data used in diabetology , 2006, Biomedical engineering online.

[64]  R. Rizza,et al.  Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans , 2006, Diabetes Care.

[65]  U. Boggi,et al.  The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients , 2007, Diabetologia.

[66]  R. Robertson.  Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? , 2007, Diabetes.

[67]  R. Robertson.  Estimation of β-Cell Mass by Metabolic Tests , 2007, Diabetes.

[68]  Pasquale Palumbo,et al.  Theoretical Biology and Medical Modelling Open Access a Discrete Single Delay Model for the Intra-venous Glucose Tolerance Test , 2022 .

[69]  S. Lakhani,et al.  A Chronic Autoimmune Disease , 2009 .